ReP USP - Resultado da busca

Artigo de periodico
Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors (2025)
Oliveira, Victor Gawriljuk Ferraro; Noske, Gabriela Dias ; Fernandes, Rafaela Sachetto ; Nakamura, Aline Minali ; Freire, Marjorie Caroline Liberato Cavalcanti ; Godoy, Mariana Ortiz de ; Bonatto, Vinícius ; Chelucci, Rafael Consolin ; Andricopulo, Adriano Defini ; Martins Júnior, Ronaldo Bragança ; Souza, Juliano de Paula ; Arruda, Eurico ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Godoy, Andre Schutzer de
Fonte: ACS Omega. Unidades: IFSC, FCFRP, FMRP
Assuntos: PROTEÍNAS, MALÁRIA, PLANEJAMENTO DE FÁRMACOS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Victor Gawriljuk Ferraro et al. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors. ACS Omega, v. 10, n. 37, p. 42711-42724 + supporting information, 2025Tradução . . Disponível em: https://doi.org/10.1021/acsomega.5c04858. Acesso em: 23 nov. 2025.
APA
Oliveira, V. G. F., Noske, G. D., Fernandes, R. S., Nakamura, A. M., Freire, M. C. L. C., Godoy, M. O. de, et al. (2025). Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors. ACS Omega, 10( 37), 42711-42724 + supporting information. doi:10.1021/acsomega.5c04858
NLM
Oliveira VGF, Noske GD, Fernandes RS, Nakamura AM, Freire MCLC, Godoy MO de, Bonatto V, Chelucci RC, Andricopulo AD, Martins Júnior RB, Souza J de P, Arruda E, Guido RVC, Oliva G, Godoy AS de. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors [Internet]. ACS Omega. 2025 ; 10( 37): 42711-42724 + supporting information.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1021/acsomega.5c04858
Vancouver
Oliveira VGF, Noske GD, Fernandes RS, Nakamura AM, Freire MCLC, Godoy MO de, Bonatto V, Chelucci RC, Andricopulo AD, Martins Júnior RB, Souza J de P, Arruda E, Guido RVC, Oliva G, Godoy AS de. Screening of medicines for malaria venture open boxes identifies potent SARS-CoV-2 papain-like protease (PLpro) inhibitors [Internet]. ACS Omega. 2025 ; 10( 37): 42711-42724 + supporting information.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1021/acsomega.5c04858
Artigo de periodico
Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection (2024)
Mestriner, Fabíola Leslie Antunes Cardoso ; Francisco, Daniely Franco ; Campos, Lígia Cristina Borges ; Couto, Ariel Emiliano Souza do ; Fraga-Silva, Thais Fernanda de Campos ; Dugaich, Vinicius Flora ; D`Avila-Mesquita, Carolina ; Zukowski Kovacs, Henrique ; Vasconcelos, Jociany Lopes de ; Milani, Elizabete Rosa ; Sá, Keyla Santos Guedes de ; Martins, Ronaldo Bragança ; Jordani, Maria Cecília ; Corsi, Carlos Alexandre Curylofo ; Barbosa, Jéssyca Michelon; Vasconcelos, Tauana Fernandes ; Menegueti, Mayra Gonçalves ; Neto, Julio; Costa, Rafael Menezes da ; Evora, Paulo Roberto Barbosa ; Arruda, Eurico ; Tostes, Rita de Cássia Aleixo ; Polonis, Katarzyna ; Bonato, Vânia Luiza Deperon ; Auxiliadora-Martins, Maria ; Ribeiro, Maurício Serra ; Becari, Christiane
Fonte: Cytokine. Unidades: FMRP, FCFRP, EERP, FOB
Assuntos: COVID-19, GLICOPROTEÍNAS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MESTRINER, Fabíola Leslie Antunes Cardoso et al. Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection. Cytokine, v. 176, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.cyto.2024.156503. Acesso em: 23 nov. 2025.
APA
Mestriner, F. L. A. C., Francisco, D. F., Campos, L. C. B., Couto, A. E. S. do, Fraga-Silva, T. F. de C., Dugaich, V. F., et al. (2024). Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection. Cytokine, 176. doi:10.1016/j.cyto.2024.156503
NLM
Mestriner FLAC, Francisco DF, Campos LCB, Couto AES do, Fraga-Silva TF de C, Dugaich VF, D`Avila-Mesquita C, Zukowski Kovacs H, Vasconcelos JL de, Milani ER, Sá KSG de, Martins RB, Jordani MC, Corsi CAC, Barbosa JM, Vasconcelos TF, Menegueti MG, Neto J, Costa RM da, Evora PRB, Arruda E, Tostes R de CA, Polonis K, Bonato VLD, Auxiliadora-Martins M, Ribeiro MS, Becari C. Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection [Internet]. Cytokine. 2024 ; 176[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.cyto.2024.156503
Vancouver
Mestriner FLAC, Francisco DF, Campos LCB, Couto AES do, Fraga-Silva TF de C, Dugaich VF, D`Avila-Mesquita C, Zukowski Kovacs H, Vasconcelos JL de, Milani ER, Sá KSG de, Martins RB, Jordani MC, Corsi CAC, Barbosa JM, Vasconcelos TF, Menegueti MG, Neto J, Costa RM da, Evora PRB, Arruda E, Tostes R de CA, Polonis K, Bonato VLD, Auxiliadora-Martins M, Ribeiro MS, Becari C. Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection [Internet]. Cytokine. 2024 ; 176[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.cyto.2024.156503
Artigo de periodico
A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19 (2024)
Oliveira, Ernna Hérida Domingues de; Monteleone-Cassiano, Ana C. ; Tavares, Lucas Alves ; Santos, Jadson Carlos dos ; Lima, Thais Melquiades de ; Gomes, Giovanni Freitas; Tanaka, Pedro Paranhos ; Monteiro, Cíntia Júnia; Munuera, Matheus Dominato; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Faça, Vitor Marcel ; Masson, Ana Paula ; Donadi, Eduardo Antônio ; Dametto, Mariangela; Bonacin, Rodrigo; Martins Júnior, Ronaldo Bragança; Arruda Neto, Eurico de; Silva, Luis Lamberti Pinto da ; Cunha, Thiago Mattar ; Passos, Geraldo Aleixo Silva
Fonte: Antiviral Research. Unidades: FMRP, FCFRP
Assuntos: COVID-19, ANTIVIRAIS, CAMUNDONGOS, INFECÇÕES RESPIRATÓRIAS, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Ernna Hérida Domingues de et al. A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19. Antiviral Research, v. 229, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.antiviral.2024.105968. Acesso em: 23 nov. 2025.
APA
Oliveira, E. H. D. de, Monteleone-Cassiano, A. C., Tavares, L. A., Santos, J. C. dos, Lima, T. M. de, Gomes, G. F., et al. (2024). A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19. Antiviral Research, 229, 1-13. doi:10.1016/j.antiviral.2024.105968
NLM
Oliveira EHD de, Monteleone-Cassiano AC, Tavares LA, Santos JC dos, Lima TM de, Gomes GF, Tanaka PP, Monteiro CJ, Munuera MD, Batah SS, Fabro AT, Faça VM, Masson AP, Donadi EA, Dametto M, Bonacin R, Martins Júnior RB, Arruda Neto E de, Silva LLP da, Cunha TM, Passos GAS. A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19 [Internet]. Antiviral Research. 2024 ; 229 1-13.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.antiviral.2024.105968
Vancouver
Oliveira EHD de, Monteleone-Cassiano AC, Tavares LA, Santos JC dos, Lima TM de, Gomes GF, Tanaka PP, Monteiro CJ, Munuera MD, Batah SS, Fabro AT, Faça VM, Masson AP, Donadi EA, Dametto M, Bonacin R, Martins Júnior RB, Arruda Neto E de, Silva LLP da, Cunha TM, Passos GAS. A mimetic peptide of ACE2 protects against SARS-CoV-2 infection and decreases pulmonary inflammation related to COVID-19 [Internet]. Antiviral Research. 2024 ; 229 1-13.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.antiviral.2024.105968
Artigo de periodico
Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data (2024)
Wang, Xin; Li, You; Shi, Ting; Bont, Louis J.; Chu, Helen Y.; Zar, Heather J.; Wahi-Singh, Bhanu; Jones, Marcus H.; Stein, Renato Tetelbom; Arruda, Eurico
Fonte: The Lancet. Unidade: FMRP
Assuntos: INFECÇÕES RESPIRATÓRIAS, BEBÊ PREMATURO, FATORES DE RISCO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Xin et al. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. The Lancet, v. 403, n. 10433, p. 1241-1253, 2024Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(24)00138-7. Acesso em: 23 nov. 2025.
APA
Wang, X., Li, Y., Shi, T., Bont, L. J., Chu, H. Y., Zar, H. J., et al. (2024). Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. The Lancet, 403( 10433), 1241-1253. doi:10.1016/S0140-6736(24)00138-7
NLM
Wang X, Li Y, Shi T, Bont LJ, Chu HY, Zar HJ, Wahi-Singh B, Jones MH, Stein RT, Arruda E. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data [Internet]. The Lancet. 2024 ; 403( 10433): 1241-1253.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/S0140-6736(24)00138-7
Vancouver
Wang X, Li Y, Shi T, Bont LJ, Chu HY, Zar HJ, Wahi-Singh B, Jones MH, Stein RT, Arruda E. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data [Internet]. The Lancet. 2024 ; 403( 10433): 1241-1253.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/S0140-6736(24)00138-7
Artigo de periodico
Neutrophil virucidal activity against SARS-CoV-2 is mediated by neutrophil extracellular traps (2024)
Almeida, Cícero José Luíz dos Ramos; Veras, Flávio Protásio ; Paiva, Isadora Marques ; Schneider, Ayda Henriques; Silva, Juliana da Costa; Gomes, Giovanni Freitas; Costa, Victor Ferreira; Silva, Bruna Manuella Souza; Caetité, Diego ; Silva, Camila Meirelles Souza; Salina, Ana Carolina Guerta ; Martins, Ronaldo; Bonilha, Caio Santos ; Cunha, Larissa Dias da ; Jamur, Maria Celia ; Silva, Luis Lamberti Pinto da ; Arruda, Eurico ; Zamboni, Dario Simões ; Louzada Júnior, Paulo ; Oliveira, Renê Donizeti Ribeiro de; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Cunha, Fernando de Queiroz
Fonte: The Journal of Infectious Diseases. Unidades: FMRP, FM
Assuntos: COVID-19, NEUTRÓFILOS, CORONAVIRUS, IMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Cícero José Luíz dos Ramos et al. Neutrophil virucidal activity against SARS-CoV-2 is mediated by neutrophil extracellular traps. The Journal of Infectious Diseases, v. 229, n. 5, p. 1352-1365, 2024Tradução . . Disponível em: https://doi.org/10.1093/infdis/jiad526. Acesso em: 23 nov. 2025.
APA
Almeida, C. J. L. dos R., Veras, F. P., Paiva, I. M., Schneider, A. H., Silva, J. da C., Gomes, G. F., et al. (2024). Neutrophil virucidal activity against SARS-CoV-2 is mediated by neutrophil extracellular traps. The Journal of Infectious Diseases, 229( 5), 1352-1365. doi:10.1093/infdis/jiad526
NLM
Almeida CJL dos R, Veras FP, Paiva IM, Schneider AH, Silva J da C, Gomes GF, Costa VF, Silva BMS, Caetité D, Silva CMS, Salina ACG, Martins R, Bonilha CS, Cunha LD da, Jamur MC, Silva LLP da, Arruda E, Zamboni DS, Louzada Júnior P, Oliveira RDR de, Alves Filho JCF, Cunha TM, Cunha F de Q. Neutrophil virucidal activity against SARS-CoV-2 is mediated by neutrophil extracellular traps [Internet]. The Journal of Infectious Diseases. 2024 ; 229( 5): 1352-1365.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1093/infdis/jiad526
Vancouver
Almeida CJL dos R, Veras FP, Paiva IM, Schneider AH, Silva J da C, Gomes GF, Costa VF, Silva BMS, Caetité D, Silva CMS, Salina ACG, Martins R, Bonilha CS, Cunha LD da, Jamur MC, Silva LLP da, Arruda E, Zamboni DS, Louzada Júnior P, Oliveira RDR de, Alves Filho JCF, Cunha TM, Cunha F de Q. Neutrophil virucidal activity against SARS-CoV-2 is mediated by neutrophil extracellular traps [Internet]. The Journal of Infectious Diseases. 2024 ; 229( 5): 1352-1365.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1093/infdis/jiad526
Artigo de periodico
Inflammatory profile of chronic rhinosinusitis with nasal polyp patients in Brazil: multicenter study (2024)
Romano, Fabrizio R.; Valera, Fabiana Cardoso Pereira ; Fornazieri, Marco A.; Voegels, Richard Louis ; Murashima, Adriana de Andrade Batista ; Silva, Lilian Eslaine Costa Mendes da ; Arruda, Eurico ; Garcia, Denny Marcos ; Tamashiro, Edwin ; Anselmo-Lima, Wilma Terezinha
Fonte: Otolaryngology–Head and Neck Surgery. Unidades: FMRP, FM
Assuntos: INFLAMAÇÃO, PÓLIPOS NASAIS, SEIOS PARANASAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMANO, Fabrizio R. et al. Inflammatory profile of chronic rhinosinusitis with nasal polyp patients in Brazil: multicenter study. Otolaryngology–Head and Neck Surgery, v. 171, n. 5, p. 1552-1561, 2024Tradução . . Disponível em: https://doi.org/10.1002/ohn.904. Acesso em: 23 nov. 2025.
APA
Romano, F. R., Valera, F. C. P., Fornazieri, M. A., Voegels, R. L., Murashima, A. de A. B., Silva, L. E. C. M. da, et al. (2024). Inflammatory profile of chronic rhinosinusitis with nasal polyp patients in Brazil: multicenter study. Otolaryngology–Head and Neck Surgery, 171( 5), 1552-1561. doi:10.1002/ohn.904
NLM
Romano FR, Valera FCP, Fornazieri MA, Voegels RL, Murashima A de AB, Silva LECM da, Arruda E, Garcia DM, Tamashiro E, Anselmo-Lima WT. Inflammatory profile of chronic rhinosinusitis with nasal polyp patients in Brazil: multicenter study [Internet]. Otolaryngology–Head and Neck Surgery. 2024 ; 171( 5): 1552-1561.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1002/ohn.904
Vancouver
Romano FR, Valera FCP, Fornazieri MA, Voegels RL, Murashima A de AB, Silva LECM da, Arruda E, Garcia DM, Tamashiro E, Anselmo-Lima WT. Inflammatory profile of chronic rhinosinusitis with nasal polyp patients in Brazil: multicenter study [Internet]. Otolaryngology–Head and Neck Surgery. 2024 ; 171( 5): 1552-1561.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1002/ohn.904
Artigo de periodico
Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 (2024)
Ferreira, Rafael R.; Martins, Ronaldo B.; Pires, Isabela Batista ; Marques, Bruno Lemes ; Costa, Karla C.M.; Lirio, Pedro Henrique Cassario ; Scomparin, Davi Silveira ; Scarante, Franciele Franco ; Batah, Sabrina Setembre ; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Rodrigues, Livia C. M. ; Tostes, Rita de Cássia Aleixo ; Fabro, Alexandre Todorovic ; Arruda, Eurico ; Campos, Alline Cristina de
Fonte: Brain, Behavior, & Immunity - Health. Unidade: FMRP
Assuntos: COVID-19, DOENÇAS CARDIOVASCULARES, NEFROPATIAS, INFLAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Rafael R. et al. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, v. 41, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbih.2024.100855. Acesso em: 23 nov. 2025.
APA
Ferreira, R. R., Martins, R. B., Pires, I. B., Marques, B. L., Costa, K. C. M., Lirio, P. H. C., et al. (2024). Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, 41. doi:10.1016/j.bbih.2024.100855
NLM
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855
Vancouver
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855
Artigo de periodico
Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study (2023)
Miyake, Marcel Menon ; Valera, Fabiana Cardoso Pereira ; Martins, Ronaldo Bragança ; Compagnoni, Inaê Mattoso ; Fantucci, Marina Zílio ; Murashima, Adriana de Andrade Batista ; Silva, Lilian Eslaine Costa Mendes da ; Lima, Thais Melquiades de ; Souza, Maria Vitória Oliveira de ; Melo, Stella Rezende; Garcia, Denny Marcos ; Aragon, Davi Casale ; Tamashiro, Edwin ; Arruda, Eurico ; Anselmo-Lima, Wilma Terezinha
Fonte: Rhinology Journal. Unidade: FMRP
Assuntos: COVID-19, PANDEMIAS, ESTUDOS PROSPECTIVOS, ESTUDOS MULTICÊNTRICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIYAKE, Marcel Menon et al. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study. Rhinology Journal, v. 62, n. 1, p. 55-62, 2023Tradução . . Disponível em: https://doi.org/10.4193/Rhin23.116. Acesso em: 23 nov. 2025.
APA
Miyake, M. M., Valera, F. C. P., Martins, R. B., Compagnoni, I. M., Fantucci, M. Z., Murashima, A. de A. B., et al. (2023). Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study. Rhinology Journal, 62( 1), 55-62. doi:10.4193/Rhin23.116
NLM
Miyake MM, Valera FCP, Martins RB, Compagnoni IM, Fantucci MZ, Murashima A de AB, Silva LECM da, Lima TM de, Souza MVO de, Melo SR, Garcia DM, Aragon DC, Tamashiro E, Arruda E, Anselmo-Lima WT. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study [Internet]. Rhinology Journal. 2023 ; 62( 1): 55-62.[citado 2025 nov. 23 ] Available from: https://doi.org/10.4193/Rhin23.116
Vancouver
Miyake MM, Valera FCP, Martins RB, Compagnoni IM, Fantucci MZ, Murashima A de AB, Silva LECM da, Lima TM de, Souza MVO de, Melo SR, Garcia DM, Aragon DC, Tamashiro E, Arruda E, Anselmo-Lima WT. Smell loss associated with SARS-CoV-2 is not clinically different from other viruses: a multicenter cohort study [Internet]. Rhinology Journal. 2023 ; 62( 1): 55-62.[citado 2025 nov. 23 ] Available from: https://doi.org/10.4193/Rhin23.116
Artigo de periodico
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients (2023)
Amaral, Natália Brasil do; Rodrigues, Tamara Silva; Giannini, Marcela Cavichioli; Lopes, Maria Isabel Fernandes; Bonjorno, Letícia Pastorelli; Menezes, Pamella Indira da Silva Oliveira; Dib, Saulo Musse; Gigante, Samara Libich Gusmão; Benatti, Maíra Nilson; Rezek, Uebe C.; Emrich-Filho, Laerte L.; Sousa, Betania A. A.; Almeida, Sérgio Couto Luna de; Luppino-Assad, Rodrigo; Veras, Flávio Protásio ; Schneider, Ayda Henriques; Leiria, Luiz Osório Silveira ; Cunha, Larissa Dias da; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Arruda Neto, Eurico de; Miranda, Carlos Henrique ; Pazin Filho, Antônio ; Martins, Maria Auxiliadora ; Borges, Marcos de Carvalho ; Fonseca, Benedito Antonio Lopes da ; Bollela, Valdes Roberto ; Del-Ben, Cristina Marta ; Cunha, Fernando de Queiroz ; Santana, Rodrigo de Carvalho ; Vilar, Fernando Crivelenti; Zamboni, Dario Simões ; Louzada Júnior, Paulo ; Oliveira, Renê Donizeti Ribeiro de
Fonte: Inflammation Research. Unidade: FMRP
Assuntos: COVID-19, CITOCINAS, PROTEÍNAS, ALCALOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Natália Brasil do et al. Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients. Inflammation Research, v. 72, n. 5, p. 895-899, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00011-023-01718-y. Acesso em: 23 nov. 2025.
APA
Amaral, N. B. do, Rodrigues, T. S., Giannini, M. C., Lopes, M. I. F., Bonjorno, L. P., Menezes, P. I. da S. O., et al. (2023). Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients. Inflammation Research, 72( 5), 895-899. doi:10.1007/s00011-023-01718-y
NLM
Amaral NB do, Rodrigues TS, Giannini MC, Lopes MIF, Bonjorno LP, Menezes PI da SO, Dib SM, Gigante SLG, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BAA, Almeida SCL de, Luppino-Assad R, Veras FP, Schneider AH, Leiria LOS, Cunha LD da, Alves Filho JCF, Cunha TM, Arruda Neto E de, Miranda CH, Pazin Filho A, Martins MA, Borges M de C, Fonseca BAL da, Bollela VR, Del-Ben CM, Cunha F de Q, Santana R de C, Vilar FC, Zamboni DS, Louzada Júnior P, Oliveira RDR de. Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients [Internet]. Inflammation Research. 2023 ; 72( 5): 895-899.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00011-023-01718-y
Vancouver
Amaral NB do, Rodrigues TS, Giannini MC, Lopes MIF, Bonjorno LP, Menezes PI da SO, Dib SM, Gigante SLG, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BAA, Almeida SCL de, Luppino-Assad R, Veras FP, Schneider AH, Leiria LOS, Cunha LD da, Alves Filho JCF, Cunha TM, Arruda Neto E de, Miranda CH, Pazin Filho A, Martins MA, Borges M de C, Fonseca BAL da, Bollela VR, Del-Ben CM, Cunha F de Q, Santana R de C, Vilar FC, Zamboni DS, Louzada Júnior P, Oliveira RDR de. Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients [Internet]. Inflammation Research. 2023 ; 72( 5): 895-899.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1007/s00011-023-01718-y
Artigo de periodico
Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men (2023)
Duarte-Silva, Murillo ; Oliveira, Camilla Narjara Simão; Fuzo, Carlos Alessandro ; Silva Neto, Pedro Vieira da; Toro, Diana Mota; Pimentel, Vinícius Eduardo; Pérez, Malena Martínez; Fraga-Silva, Thais Fernanda de Campos ; Carvalho, Jonatan Constança Silva de; Santos Neto, Firmino Martins dos; Martins Júnior, Ronaldo Bragança; Arruda Neto, Eurico de; Vilar, Fernando Crivelenti; Degiovani, Augusto Marcussi; Ostini, Fátima M.; Feitosa, Marley Ribeiro; Parra, Rogério Serafim ; Gaspar, Gilberto Gambero ; Rocha, José Joaquim Ribeiro da; Féres, Omar; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina Costa; Russo, Elisa Maria de Sousa ; Bonato, Vânia Luiza Deperon ; Santos, Isabel Kinney Ferreira de Miranda ; Sorgi, Carlos Arterio ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Cardoso, Cristina Ribeiro de Barros
Fonte: Brain, Behavior, and Immunity. Unidades: FMRP, FCFRP, EERP, FFCLRP
Assuntos: TESTOSTERONA, DIIDROTESTOSTERONA, RECEPTORES ADRENÉRGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE-SILVA, Murillo et al. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men. Brain, Behavior, and Immunity, v. 114, p. 275-286, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.bbi.2023.08.026. Acesso em: 23 nov. 2025.
APA
Duarte-Silva, M., Oliveira, C. N. S., Fuzo, C. A., Silva Neto, P. V. da, Toro, D. M., Pimentel, V. E., et al. (2023). Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men. Brain, Behavior, and Immunity, 114, 275-286. doi:10.1016/j.bbi.2023.08.026
NLM
Duarte-Silva M, Oliveira CNS, Fuzo CA, Silva Neto PV da, Toro DM, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Carvalho JCS de, Santos Neto FM dos, Martins Júnior RB, Arruda Neto E de, Vilar FC, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Santos IKF de M, Sorgi CA, Dias-Baruffi M, Faccioli LH, Cardoso CR de B. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men [Internet]. Brain, Behavior, and Immunity. 2023 ; 114 275-286.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.bbi.2023.08.026
Vancouver
Duarte-Silva M, Oliveira CNS, Fuzo CA, Silva Neto PV da, Toro DM, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Carvalho JCS de, Santos Neto FM dos, Martins Júnior RB, Arruda Neto E de, Vilar FC, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Gaspar GG, Rocha JJR da, Féres O, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Santos IKF de M, Sorgi CA, Dias-Baruffi M, Faccioli LH, Cardoso CR de B. Divergent androgenic modulation of SARS-CoV-2 infection cooperates with dysregulated immune response to dictate worse COVID-19 outcomes in men [Internet]. Brain, Behavior, and Immunity. 2023 ; 114 275-286.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.bbi.2023.08.026
Artigo de periodico
C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps (2023)
Silva, Bruna Manuella Souza; Gomes, Giovanni Freitas; Veras, Flávio Protásio ; Cambier, Seppe; Silva, Gabriel Victor Lucena da ; Quadros, Andreza Urba de; Caetité, Diego Brito ; Nascimento, Daniele Carvalho ; Silva, Camilla M.; Silva, Juliana C. ; Damasceno, Samara; Schneider, Ayda Henriques ; Beretta, Fabio; Batah, Sabrina Setembre ; Castro, Ícaro Maia Santos ; Paiva, Isadora Marques ; Rodrigues, Tamara Silva ; Salina, Ana Carolina Guerta ; Martins Júnior, Ronaldo Bragança; Cebinelli, Guilherme Cesar Martelossi ; Bibo, Naira Lopes; Jorge, Daniel M.; Nakaya, Helder Takashi Imoto ; Zamboni, Dario Simões ; Leiria, Luiz Osório Silveira ; Fabro, Alexandre Todorovic ; Alves Filho, José Carlos Farias ; Arruda Neto, Eurico de; Louzada Júnior, Paulo ; Oliveira, Renê Donizete Ribeiro de; Cunha, Larissa Dias da; Mol, Pierre Van; Vanderbeke, Lore; Feys, Simon; Wauters, Els; Brandolini, Laura; Aramini, Andrea; Cunha, Fernando Q.; Köhl, Jörg; Allegretti, Marcello; Lambrechts, Diether; Wauters, Joost; Proost, Paul; Cunha, Thiago Mattar
Fonte: Journal of Clinical Investigation. Unidades: FCFRP, FMRP
Assuntos: COVID-19, PULMÃO, INFLAMAÇÃO, IMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Bruna Manuella Souza et al. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps. Journal of Clinical Investigation, v. 133, n. 12, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.1172/JCI163105. Acesso em: 23 nov. 2025.
APA
Silva, B. M. S., Gomes, G. F., Veras, F. P., Cambier, S., Silva, G. V. L. da, Quadros, A. U. de, et al. (2023). C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps. Journal of Clinical Investigation, 133( 12), 1-18. doi:10.1172/JCI163105
NLM
Silva BMS, Gomes GF, Veras FP, Cambier S, Silva GVL da, Quadros AU de, Caetité DB, Nascimento DC, Silva CM, Silva JC, Damasceno S, Schneider AH, Beretta F, Batah SS, Castro ÍMS, Paiva IM, Rodrigues TS, Salina ACG, Martins Júnior RB, Cebinelli GCM, Bibo NL, Jorge DM, Nakaya HTI, Zamboni DS, Leiria LOS, Fabro AT, Alves Filho JCF, Arruda Neto E de, Louzada Júnior P, Oliveira RDR de, Cunha LD da, Mol PV, Vanderbeke L, Feys S, Wauters E, Brandolini L, Aramini A, Cunha FQ, Köhl J, Allegretti M, Lambrechts D, Wauters J, Proost P, Cunha TM. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps [Internet]. Journal of Clinical Investigation. 2023 ; 133( 12): 1-18.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1172/JCI163105
Vancouver
Silva BMS, Gomes GF, Veras FP, Cambier S, Silva GVL da, Quadros AU de, Caetité DB, Nascimento DC, Silva CM, Silva JC, Damasceno S, Schneider AH, Beretta F, Batah SS, Castro ÍMS, Paiva IM, Rodrigues TS, Salina ACG, Martins Júnior RB, Cebinelli GCM, Bibo NL, Jorge DM, Nakaya HTI, Zamboni DS, Leiria LOS, Fabro AT, Alves Filho JCF, Arruda Neto E de, Louzada Júnior P, Oliveira RDR de, Cunha LD da, Mol PV, Vanderbeke L, Feys S, Wauters E, Brandolini L, Aramini A, Cunha FQ, Köhl J, Allegretti M, Lambrechts D, Wauters J, Proost P, Cunha TM. C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps [Internet]. Journal of Clinical Investigation. 2023 ; 133( 12): 1-18.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1172/JCI163105
Artigo de periodico
Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model (2023)
Veras, Flávio Protásio ; Gomes, Giovanni Freitas; Silva, Bruna Machado da; Caetité, Diego ; Almeida, Cícero José Luíz dos Ramos; Silva, Camila Meirelles de Souza; Schneider, Ayda Henriques; Córneo, Emily S.; Bonilha, Caio Santos ; Batah, Sabrina Setembre ; Martins, Ronaldo Bragança; Arruda Neto, Eurico de; Fabro, Alexandre Todorovic ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Cunha, Fernando de Queiroz
Fonte: Respiratory Research. Unidade: FMRP
Assuntos: NEUTRÓFILOS, PULMÃO, COVID-19, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VERAS, Flávio Protásio et al. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respiratory Research, v. 24, n. 1, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.1186/s12931-023-02336-2. Acesso em: 23 nov. 2025.
APA
Veras, F. P., Gomes, G. F., Silva, B. M. da, Caetité, D., Almeida, C. J. L. dos R., Silva, C. M. de S., et al. (2023). Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respiratory Research, 24( 1), 1-11. doi:10.1186/s12931-023-02336-2
NLM
Veras FP, Gomes GF, Silva BM da, Caetité D, Almeida CJL dos R, Silva CM de S, Schneider AH, Córneo ES, Bonilha CS, Batah SS, Martins RB, Arruda Neto E de, Fabro AT, Alves Filho JCF, Cunha TM, Cunha F de Q. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model [Internet]. Respiratory Research. 2023 ; 24( 1): 1-11.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1186/s12931-023-02336-2
Vancouver
Veras FP, Gomes GF, Silva BM da, Caetité D, Almeida CJL dos R, Silva CM de S, Schneider AH, Córneo ES, Bonilha CS, Batah SS, Martins RB, Arruda Neto E de, Fabro AT, Alves Filho JCF, Cunha TM, Cunha F de Q. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model [Internet]. Respiratory Research. 2023 ; 24( 1): 1-11.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1186/s12931-023-02336-2
Artigo de periodico
COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis (2023)
Barreto, Ester A.; Cruz, Amanda S.; Veras, Flávio Protásio ; Martins, Ronaldo Bragança ; Bernardelli, Rafaella S.; Paiva, Isadora Marques ; Lima, Thais Melquiades de; Singh, Youvika ; Guimaraes, Raphael C.; Damasceno, Samara; Pereira, Nayara; Alves, João Manoel; Gonçalves, Tiago T.; Forato, Julia; Muraro, Stéfanie P.; Souza, Gabriela F.; Batah, Sabrina Setembre ; Proença-Modena, José L.; Mori, Marcelo A.; Cunha, Fernando de Queiroz ; Louzada Júnior, Paulo ; Cunha, Thiago Mattar ; Nakaya, Helder Takashi Imoto ; Fabro, Alexandre Todorovic ; Oliveira, Renê Donizeti Ribeiro de; Arruda, Eurico ; Rea, Rosângela; Réa Neto, Álvaro; Silva, Miguel M Fernandes da; Leiria, Luiz Osório Silveira
Fonte: Proceedings of the National Academy of Sciences. Unidades: FMRP, FCF
Assuntos: GLICOSE, COVID-19, GLICOGENOSE, HIPERGLICEMIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRETO, Ester A. et al. COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis. Proceedings of the National Academy of Sciences, v. 120, n. 21, p. 1-10, 2023Tradução . . Disponível em: https://doi.org/10.1073/pnas.2217119120. Acesso em: 23 nov. 2025.
APA
Barreto, E. A., Cruz, A. S., Veras, F. P., Martins, R. B., Bernardelli, R. S., Paiva, I. M., et al. (2023). COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis. Proceedings of the National Academy of Sciences, 120( 21), 1-10. doi:10.1073/pnas.2217119120
NLM
Barreto EA, Cruz AS, Veras FP, Martins RB, Bernardelli RS, Paiva IM, Lima TM de, Singh Y, Guimaraes RC, Damasceno S, Pereira N, Alves JM, Gonçalves TT, Forato J, Muraro SP, Souza GF, Batah SS, Proença-Modena JL, Mori MA, Cunha F de Q, Louzada Júnior P, Cunha TM, Nakaya HTI, Fabro AT, Oliveira RDR de, Arruda E, Rea R, Réa Neto Á, Silva MMF da, Leiria LOS. COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis [Internet]. Proceedings of the National Academy of Sciences. 2023 ; 120( 21): 1-10.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1073/pnas.2217119120
Vancouver
Barreto EA, Cruz AS, Veras FP, Martins RB, Bernardelli RS, Paiva IM, Lima TM de, Singh Y, Guimaraes RC, Damasceno S, Pereira N, Alves JM, Gonçalves TT, Forato J, Muraro SP, Souza GF, Batah SS, Proença-Modena JL, Mori MA, Cunha F de Q, Louzada Júnior P, Cunha TM, Nakaya HTI, Fabro AT, Oliveira RDR de, Arruda E, Rea R, Réa Neto Á, Silva MMF da, Leiria LOS. COVID-19-related hyperglycemia is associated with infection of hepatocytes and stimulation of gluconeogenesis [Internet]. Proceedings of the National Academy of Sciences. 2023 ; 120( 21): 1-10.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1073/pnas.2217119120
Artigo de periodico
HIV-1 nef changes the proteome of T cells extracellular vesicles depleting IFITMs and other antiviral factors (2023)
Januário, Mara Elisama da Silva; Costa, Cristina Santos da; Tavares, Lucas Alves ; Oliveira, Ana K.; Januário, Yunan C.; Carvalho, Andréia N.; Cassiano, Murilo Henrique Anzolini ; Rodrigues, Roger Luiz; Miller, Michael E.; Palameta, Soledad ; Arns, Clarice W.; Arruda, Eurico ; Leme, Adriana F. Paes; Silva, Luis Lamberti Pinto da
Fonte: Molecular and Cellular Proteomics. Unidades: FMRP, ICB
Assuntos: ANTIVIRAIS, INFECÇÕES POR HIV, INTERFERONS, PROTEÔMICA, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANUÁRIO, Mara Elisama da Silva et al. HIV-1 nef changes the proteome of T cells extracellular vesicles depleting IFITMs and other antiviral factors. Molecular and Cellular Proteomics, v. 22, n. 12, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.mcpro.2023.100676. Acesso em: 23 nov. 2025.
APA
Januário, M. E. da S., Costa, C. S. da, Tavares, L. A., Oliveira, A. K., Januário, Y. C., Carvalho, A. N., et al. (2023). HIV-1 nef changes the proteome of T cells extracellular vesicles depleting IFITMs and other antiviral factors. Molecular and Cellular Proteomics, 22( 12), 1-17. doi:10.1016/j.mcpro.2023.100676
NLM
Januário ME da S, Costa CS da, Tavares LA, Oliveira AK, Januário YC, Carvalho AN, Cassiano MHA, Rodrigues RL, Miller ME, Palameta S, Arns CW, Arruda E, Leme AFP, Silva LLP da. HIV-1 nef changes the proteome of T cells extracellular vesicles depleting IFITMs and other antiviral factors [Internet]. Molecular and Cellular Proteomics. 2023 ; 22( 12): 1-17.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.mcpro.2023.100676
Vancouver
Januário ME da S, Costa CS da, Tavares LA, Oliveira AK, Januário YC, Carvalho AN, Cassiano MHA, Rodrigues RL, Miller ME, Palameta S, Arns CW, Arruda E, Leme AFP, Silva LLP da. HIV-1 nef changes the proteome of T cells extracellular vesicles depleting IFITMs and other antiviral factors [Internet]. Molecular and Cellular Proteomics. 2023 ; 22( 12): 1-17.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.mcpro.2023.100676
Artigo de periodico
Tonsils are major sites of persistence of SARS-CoV-2 in children (2023)
Lima, Thais Melquiades de; Martins Júnior, Ronaldo Bragança; Miura, Carolina Sponchiado; Souza, Maria Vitória Oliveira de; Cassiano, Murilo Henrique Anzolini ; Rodrigues, Tamara Silva ; Veras, Flávio Protásio ; Sousa, Josane de Freitas ; Gomes, Rogério; Almeida, Glaucia Maria ; Melo, Stella Rezende; Silva, Gabriela Condé da; Dias, Matheus; Capato, Carlos Fabiano; Silva, Maria Lúcia; Luiz, Veridiana Ester Dias de Barros; Carenzi, Lucas Rodrigues; Zamboni, Dario Simões ; Jorge, Daniel Macedo de Melo; Cunha, Fernando de Queiroz ; Tamashiro, Edwin ; Anselmo-Lima, Wilma Terezinha ; Valera, Fabiana Cardoso Pereira ; Arruda Neto, Eurico de
Fonte: Microbiology Spectrum. Unidades: FCFRP, FMRP
Assuntos: TONSILA, ADENOIDES, VÍRUS, DOENÇAS INFECCIOSAS, PEDIATRIA, OTORRINOLARINGOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Thais Melquiades de et al. Tonsils are major sites of persistence of SARS-CoV-2 in children. Microbiology Spectrum, v. 11, n. 5, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.1128/spectrum.01347-23. Acesso em: 23 nov. 2025.
APA
Lima, T. M. de, Martins Júnior, R. B., Miura, C. S., Souza, M. V. O. de, Cassiano, M. H. A., Rodrigues, T. S., et al. (2023). Tonsils are major sites of persistence of SARS-CoV-2 in children. Microbiology Spectrum, 11( 5), 1-14. doi:10.1128/spectrum.01347-23
NLM
Lima TM de, Martins Júnior RB, Miura CS, Souza MVO de, Cassiano MHA, Rodrigues TS, Veras FP, Sousa J de F, Gomes R, Almeida GM, Melo SR, Silva GC da, Dias M, Capato CF, Silva ML, Luiz VED de B, Carenzi LR, Zamboni DS, Jorge DM de M, Cunha F de Q, Tamashiro E, Anselmo-Lima WT, Valera FCP, Arruda Neto E de. Tonsils are major sites of persistence of SARS-CoV-2 in children [Internet]. Microbiology Spectrum. 2023 ; 11( 5): 1-14.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1128/spectrum.01347-23
Vancouver
Lima TM de, Martins Júnior RB, Miura CS, Souza MVO de, Cassiano MHA, Rodrigues TS, Veras FP, Sousa J de F, Gomes R, Almeida GM, Melo SR, Silva GC da, Dias M, Capato CF, Silva ML, Luiz VED de B, Carenzi LR, Zamboni DS, Jorge DM de M, Cunha F de Q, Tamashiro E, Anselmo-Lima WT, Valera FCP, Arruda Neto E de. Tonsils are major sites of persistence of SARS-CoV-2 in children [Internet]. Microbiology Spectrum. 2023 ; 11( 5): 1-14.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1128/spectrum.01347-23
Artigo de periodico
Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor (2023)
Rodrigues, Daniel ; Machado, Mirele Resende ; Alves, Juliano Vilela ; Fraga-Silva, Thais Fernanda de Campos ; Martins, Ronaldo Bragança ; Campos, Lígia Cristina Borges ; Francisco, Daniely Franco ; Couto, Ariel Emiliano Souza do ; Bonato, Vânia Luiza Deperon ; Arruda, Eurico ; Becari, Christiane ; Auxiliadora-Martins, Maria ; Louzada Júnior, Paulo ; Costa, Rafael Menezes da ; Tostes, Rita de Cássia Aleixo
Fonte: American Journal of Physiology. Heart and Circulatory Physiology. Unidades: FCFRP, FMRP, FOB
Assuntos: CÉLULAS ENDOTELIAIS, CITOCINAS, COVID-19, ANORMALIDADES CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Daniel et al. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor. American Journal of Physiology. Heart and Circulatory Physiology, v. 325, n. 2, p. H252–H263 Aug. 2023, 2023Tradução . . Disponível em: https://doi.org/10.1152/ajpheart.00096.2023. Acesso em: 23 nov. 2025.
APA
Rodrigues, D., Machado, M. R., Alves, J. V., Fraga-Silva, T. F. de C., Martins, R. B., Campos, L. C. B., et al. (2023). Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor. American Journal of Physiology. Heart and Circulatory Physiology, 325( 2), H252–H263 Aug. 2023. doi:10.1152/ajpheart.00096.2023
NLM
Rodrigues D, Machado MR, Alves JV, Fraga-Silva TF de C, Martins RB, Campos LCB, Francisco DF, Couto AES do, Bonato VLD, Arruda E, Becari C, Auxiliadora-Martins M, Louzada Júnior P, Costa RM da, Tostes R de CA. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor [Internet]. American Journal of Physiology. Heart and Circulatory Physiology. 2023 ; 325( 2): H252–H263 Aug. 2023.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1152/ajpheart.00096.2023
Vancouver
Rodrigues D, Machado MR, Alves JV, Fraga-Silva TF de C, Martins RB, Campos LCB, Francisco DF, Couto AES do, Bonato VLD, Arruda E, Becari C, Auxiliadora-Martins M, Louzada Júnior P, Costa RM da, Tostes R de CA. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor [Internet]. American Journal of Physiology. Heart and Circulatory Physiology. 2023 ; 325( 2): H252–H263 Aug. 2023.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1152/ajpheart.00096.2023
Artigo de periodico
The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation (2023)
Lima, Mikhael Haruo Fernandes de ; Machado, Caio Cavalcante ; Nascimento, Daniele Carvalho ; Silva, Camila Meirelles de Souza; Toller-kawahisa, Juliana Escher ; Rodrigues, Tamara Silva ; Veras, Flávio Protásio ; Pontelli, Marjorie Cornejo ; Castro, Ítalo Araújo de ; Zamboni, Dario Simões ; Alves Filho, José Carlos Farias ; Cunha, Thiago Mattar ; Arruda Neto, Eurico de; Cunha, Larissa Dias da; Oliveira, Renê Donizeti Ribeiro de; Cunha, Fernando Queiroz ; Louzada Júnior, Paulo
Fonte: Scientific Reports. Unidades: FMRP, FCFRP
Assuntos: BACTEREMIA, COVID-19, RECEPTORES IMUNOLÓGICOS, RESPIRAÇÃO ARTIFICIAL, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Mikhael Haruo Fernandes de et al. The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation. Scientific Reports, v. 13, n. 1, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-39924-7. Acesso em: 23 nov. 2025.
APA
Lima, M. H. F. de, Machado, C. C., Nascimento, D. C., Silva, C. M. de S., Toller-kawahisa, J. E., Rodrigues, T. S., et al. (2023). The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation. Scientific Reports, 13( 1), 1-12. doi:10.1038/s41598-023-39924-7
NLM
Lima MHF de, Machado CC, Nascimento DC, Silva CM de S, Toller-kawahisa JE, Rodrigues TS, Veras FP, Pontelli MC, Castro ÍA de, Zamboni DS, Alves Filho JCF, Cunha TM, Arruda Neto E de, Cunha LD da, Oliveira RDR de, Cunha FQ, Louzada Júnior P. The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation [Internet]. Scientific Reports. 2023 ; 13( 1): 1-12.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1038/s41598-023-39924-7
Vancouver
Lima MHF de, Machado CC, Nascimento DC, Silva CM de S, Toller-kawahisa JE, Rodrigues TS, Veras FP, Pontelli MC, Castro ÍA de, Zamboni DS, Alves Filho JCF, Cunha TM, Arruda Neto E de, Cunha LD da, Oliveira RDR de, Cunha FQ, Louzada Júnior P. The TIGIT+ T regulatory cells subset associates with nosocomial infection and fatal outcome in COVID-19 patients under mechanical ventilation [Internet]. Scientific Reports. 2023 ; 13( 1): 1-12.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1038/s41598-023-39924-7
Artigo de periodico
Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production (2023)
Córneo, Emily S.; Veras, Flávio Protásio ; Gomes, Giovanni F.; Schneider, Ayda Henriques ; Silva, Bruna Manuella Souza; Almeida, Cícero José Luíz dos Ramos; Silva, Camila M.; Martins, Ronaldo B.; Batah, Sabrina Setembre ; Simon, Carla S.; Prestes, Gabriele da S.; Alves Filho, José Carlos Farias ; Arruda, Eurico ; Louzada Júnior, Paulo ; Oliveira, Renê Donizeti Ribeiro de; Fabro, Alexandre Todorovic ; Cunha, Thiago Mattar ; Cunha, Fernando de Queiroz ; Dal-Pizzol, Felipe
Fonte: Clinical Immunology. Unidades: FMRP, ESALQ
Assuntos: COVID-19, NEUTRÓFILOS, CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÓRNEO, Emily S. et al. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production. Clinical Immunology, v. 257, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2023.109836. Acesso em: 23 nov. 2025.
APA
Córneo, E. S., Veras, F. P., Gomes, G. F., Schneider, A. H., Silva, B. M. S., Almeida, C. J. L. dos R., et al. (2023). Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production. Clinical Immunology, 257, 1-12. doi:10.1016/j.clim.2023.109836
NLM
Córneo ES, Veras FP, Gomes GF, Schneider AH, Silva BMS, Almeida CJL dos R, Silva CM, Martins RB, Batah SS, Simon CS, Prestes G da S, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RDR de, Fabro AT, Cunha TM, Cunha F de Q, Dal-Pizzol F. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production [Internet]. Clinical Immunology. 2023 ; 257 1-12.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.clim.2023.109836
Vancouver
Córneo ES, Veras FP, Gomes GF, Schneider AH, Silva BMS, Almeida CJL dos R, Silva CM, Martins RB, Batah SS, Simon CS, Prestes G da S, Alves Filho JCF, Arruda E, Louzada Júnior P, Oliveira RDR de, Fabro AT, Cunha TM, Cunha F de Q, Dal-Pizzol F. Enoxaparin improves COVID-19 by reducing Neutrophils Extracellular Traps (NETs) production [Internet]. Clinical Immunology. 2023 ; 257 1-12.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1016/j.clim.2023.109836
Artigo de periodico
High-dose convalescent plasma for treatment of severe COVID-19 (2022)
De Santis, Gil Cunha; Oliveira, Luciana Correa; Garibaldi, Pedro Manoel Marques; Almado, Carlos E. L.; Croda, Julio; Arcanjo, Ghislaine G.A.; Oliveira, Érika A. F.; Tonacio, Adriana C.; Langhi Júnior, Dante M.; Bordin, José O.; Gilio, Renato N.; Palma, Leonardo C.; Santos, Elaine V.; Haddad, Simone Kashima; Prado, Benedito P. A.; Pontelli, Marjorie Cornejo; Gomes, Rogério; Miranda, Carlos Henrique; Martins, Maria Auxiliadora; Covas, Dimas Tadeu; Arruda, Eurico; Fonseca, Benedito Antonio Lopes da; Calado, Rodrigo Tocantins
Fonte: Emerging Infectious Diseases. Unidade: FMRP
Assuntos: COVID-19, IMUNIZAÇÃO PASSIVA, PLASMA, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DE SANTIS, Gil Cunha et al. High-dose convalescent plasma for treatment of severe COVID-19. Emerging Infectious Diseases, v. 28, n. 3, p. 548-555, 2022Tradução . . Disponível em: https://doi.org/10.3201/eid2803.212299. Acesso em: 23 nov. 2025.
APA
De Santis, G. C., Oliveira, L. C., Garibaldi, P. M. M., Almado, C. E. L., Croda, J., Arcanjo, G. G. A., et al. (2022). High-dose convalescent plasma for treatment of severe COVID-19. Emerging Infectious Diseases, 28( 3), 548-555. doi:10.3201/eid2803.212299
NLM
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi Júnior DM, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA, Pontelli MC, Gomes R, Miranda CH, Martins MA, Covas DT, Arruda E, Fonseca BAL da, Calado RT. High-dose convalescent plasma for treatment of severe COVID-19 [Internet]. Emerging Infectious Diseases. 2022 ; 28( 3): 548-555.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3201/eid2803.212299
Vancouver
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi Júnior DM, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA, Pontelli MC, Gomes R, Miranda CH, Martins MA, Covas DT, Arruda E, Fonseca BAL da, Calado RT. High-dose convalescent plasma for treatment of severe COVID-19 [Internet]. Emerging Infectious Diseases. 2022 ; 28( 3): 548-555.[citado 2025 nov. 23 ] Available from: https://doi.org/10.3201/eid2803.212299
Artigo de periodico
Celastrol: a lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion (2022)
Fuzo, Carlos Alessandro; Martins Júnior, Ronaldo Bragança; Fraga-Silva, Thais Fernanda de Campos; Amstalden, Martin Krähenbühl; Leo, Thais Canassa de ; Souza, Juliano P.; Lima, Thais Melquiades de; Faccioli, Lucia Helena ; Okamoto, Débora Noma; Juliano, Maria Aparecida; França, Suzelei C.; Juliano, Luiz; Bonato, Vânia Luiza Deperon; Arruda Neto, Eurico de; Dias-Baruffi, Marcelo
Fonte: Drug Development Research. Unidades: FCFRP, FMRP
Assuntos: ANTIVIRAIS, COVID-19, CORONAVIRUS, INTERLEUCINA 6
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZO, Carlos Alessandro et al. Celastrol: a lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion. Drug Development Research, v. 83, n. 7, p. 1623-1640, 2022Tradução . . Disponível em: https://doi.org/10.1002/ddr.21982. Acesso em: 23 nov. 2025.
APA
Fuzo, C. A., Martins Júnior, R. B., Fraga-Silva, T. F. de C., Amstalden, M. K., Leo, T. C. de, Souza, J. P., et al. (2022). Celastrol: a lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion. Drug Development Research, 83( 7), 1623-1640. doi:10.1002/ddr.21982
NLM
Fuzo CA, Martins Júnior RB, Fraga-Silva TF de C, Amstalden MK, Leo TC de, Souza JP, Lima TM de, Faccioli LH, Okamoto DN, Juliano MA, França SC, Juliano L, Bonato VLD, Arruda Neto E de, Dias-Baruffi M. Celastrol: a lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion [Internet]. Drug Development Research. 2022 ; 83( 7): 1623-1640.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1002/ddr.21982
Vancouver
Fuzo CA, Martins Júnior RB, Fraga-Silva TF de C, Amstalden MK, Leo TC de, Souza JP, Lima TM de, Faccioli LH, Okamoto DN, Juliano MA, França SC, Juliano L, Bonato VLD, Arruda Neto E de, Dias-Baruffi M. Celastrol: a lead compound that inhibits SARS-CoV-2 replication, the activity of viral and human cysteine proteases, and virus-induced IL-6 secretion [Internet]. Drug Development Research. 2022 ; 83( 7): 1623-1640.[citado 2025 nov. 23 ] Available from: https://doi.org/10.1002/ddr.21982

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos